Report cover image

Chronic Kidney Disease Drugs Market -Global Trends and Forecasts(2025 to 2034)

Publisher Factview Research
Published Nov 02, 2025
Length 202 Pages
SKU # FAVR20572961

Description

Chronic Kidney Disease Drugs Market Size And Forecast

According to Factview Research, the Chronic Kidney Disease Drugs Market was valued at USD 13.18 Billion in 2024 and is projected to reach USD 16.82 Billion by 2034, growing at a CAGR of 2.7% from 2025 to 2034.

Global Chronic Kidney Disease Drugs Market Outlook

The Global chronic kidney disease (CKD) market is majorly driven by the rising incidence of chronic kidney disease among patients Globally. This bolsters the need for novel treatments to improve the quality of life of patients. According to the Centers for Disease Control and Prevention report published in 2025, about 37 million people are estimated to have chronic kidney disease in the United States. Also, increasing the geriatric population, increasing research and development activities in the development of CKD drugs, and favorable reimbursement policies in some countries are some other factors expected to propel the market growth. Moreover, due to the high unmet needs, technological advancements in treatment and innovations are further expected to fuel the market growth. However, increasing inclinations of generic drugs and poor patient compliance in some countries, are expected to hamper the growth of the market.

Global Chronic Kidney Disease Drugs Market Competitive Landscape

The Global Chronic Kidney Disease Drugs Market study report will provide a valuable insight with an emphasis on Global market including some of the major players such as AstraZeneca, Pfizer Inc., Amgen Inc., FibroGen, Inc., GlaxoSmithKline plc., F. Hoffmann-La Roche, AbbVie Inc., Akebia Therapeutics, Inc., Teva Pharmaceutical Industries Ltd., and Johnson & Johnson Services, Inc.

Table of Contents

202 Pages
1 Introduction Of Global Chronic Kidney Disease Drugs Market
1.1 Overview Of The Market
1.2 Scope Of Report
1.3 Assumptions
2 Executive Summary
3 Research Methodology Of Factview Research
3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List Of Data Sources
4 Global Chronic Kidney Disease Drugs Market Outlook
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
5 Global Chronic Kidney Disease Drugs Market, By Drug Class
5.1 Overview
5.2 Ace Inhibitors
5.3 Angiotensin-ii Receptor Blockers
5.4 Beta Blockers
5.5 Calcium Channel Blockers
5.6 Diuretics
5.7 Erythropoiesis-stimulating Agents (Esas)
5.8 Others
6 Global Chronic Kidney Disease Drugs Market, By End-user
6.1 Overview
6.2 Hospitals
6.3 Specialty Clinics
7 Global Chronic Kidney Disease Drugs Market, By Geography
7.1 Overview
7.2 North America
7.2.1 U.S.
7.2.2 Canada
7.2.3 Mexico
7.3 Europe
7.3.1 Germany
7.3.2 U.K.
7.3.3 France
7.3.4 Rest Of Europe
7.4 Asia Pacific
7.4.1 China
7.4.2 Japan
7.4.3 India
7.4.4 Rest Of Asia Pacific
7.5 Rest Of The World
7.5.1 Latin America
7.5.2 Middle East
8 Global Chronic Kidney Disease Drugs Market Competitive Landscape
8.1 Overview
8.2 Company Market Ranking
8.3 Key Development Strategies
9 Company Profiles
9.1 Astrazeneca
9.1.1 Overview
9.1.2 Financial Performance
9.1.3 Product Outlook
9.1.4 Key Developments
9.2 Pfizer Inc.
9.2.1 Overview
9.2.2 Financial Performance
9.2.3 Product Outlook
9.2.4 Key Developments
9.3 Amgen Inc.
9.3.1 Overview
9.3.2 Financial Performance
9.3.3 Product Outlook
9.3.4 Key Developments
9.4 Fibrogen, Inc.
9.4.1 Overview
9.4.2 Financial Performance
9.4.3 Product Outlook
9.4.4 Key Developments
9.5 Glaxosmithkline Plc.
9.5.1 Overview
9.5.2 Financial Performance
9.5.3 Product Outlook
9.5.4 Key Developments
9.6 F. Hoffmann-la Roche
9.6.1 Overview
9.6.2 Financial Performance
9.6.3 Product Outlook
9.6.4 Key Developments
9.7 Abbvie Inc.
9.7.1 Overview
9.7.2 Financial Performance
9.7.3 Product Outlook
9.7.4 Key Developments
9.8 Akebia Therapeutics, Inc.
9.8.1 Overview
9.8.2 Financial Performance
9.8.3 Product Outlook
9.8.4 Key Developments
9.9 Teva Pharmaceutical Industries Ltd.
9.9.1 Overview
9.9.2 Financial Performance
9.9.3 Product Outlook
9.9.4 Key Developments
9.10 Johnson &Amp; Johnson Services, Inc.
9.10.1 Overview
9.10.2 Financial Performance
9.10.3 Product Outlook
9.10.4 Key Developments
10 Appendix
10.1 Related Research

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us